课题基金 / 基金详情

RESEARCH ON HUMAN AIRWAY EPITHELIUM ACTING AS ALLOANTIGEN-PRESENTING CELLS

RESEARCH ON HUMAN AIRWAY EPITHELIUM ACTING AS ALLOANTIGEN-PRESENTING CELLS
人气道上皮作为同种抗原呈递细胞的研究
批准号:
06454397
负责人:
NAKAJIMA Jun
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKAJIMA Jun的其他基金

相似基金

相关文献

中文摘要
翻译
在肺移植中,循环中的白细胞和血管内皮细胞被认为是抗原提呈细胞(APC)。在本研究中,我们首先确定了呼吸道上皮细胞是否具有APC的功能。将BEAS-2B(B2B,1×10^5个/ml)不朽的人上皮细胞株BEAS-2B(B2B,1×10^5个/ml)与其表面的共刺激分子ICAM-1、LFA-3和B7一起结构性地表达HLAI类和II类抗原,并将其转移到来自健康志愿者的同种异体人外周血淋巴细胞(PBL)的10ml完全培养液中(1*10^6个/ml)。混合淋巴细胞-上皮细胞系(ML-AECL)培养3d,收获。另设单向混合淋巴细胞培养(MLC)作为对照研究。用EASIA法测定上清液中IL-10的浓度。MLC组IL-10浓度未见明显升高(正负11.8pg/ml,N=5),但显著降低…。更多的是ML-AECL(128pg/ml,N=5,p=0.043)。B2B刺激诱导同种异体淋巴细胞群增殖并分泌IL-10。据报道,Th2是辅助性T细胞的一个亚群,它分泌IL-10,而IL-10反过来抑制Th1和细胞毒性T细胞(CTL)的增殖和激活。其次,我们研究了共刺激分子在B2B中的作用。B2B用抗HLAI类、抗HLAII类、抗ICAM-1、抗LFA-3或抗B7单抗处理B2B,然后培养ML-AECL并收获。采用四甲基偶氮唑蓝(四甲基偶氮唑蓝)法检测细胞增殖。掩蔽B2B细胞表面的HLAI、II类或LFA-3后,MTT值(相对于对照组的百分比)明显低于对照组。在B2B细胞和同种异体淋巴细胞的混合培养中,淋巴细胞识别BEAS-2B上表达的MHC-I和II类抗原,BEAS-2B上的LFA-3也有助于激活淋巴细胞的同种异体反应。较少
英文摘要
In lung allotransplantation, circulating leukocytes and vascular endothelial cells have been considered to be antigen-presenting cells (APCs). First in this research, we determined whether airway epithelial cells function as APCs.An immortal human epithelial cell line, BEAS-2B (B2B,1*10^5 cells/ml), which constitutively expresses both HLA-class I and class II antigens along with costimulatory molecules, ICAM-1, LFA-3, and B7 on its surface, was irradiated (50Gy) and transferred to 10ml of complete culture medium with allogeneic human peripheral blood lymphocyte (PBL) (1*10^6 cells/ml) from a healthy volunteer. The mixed lymphocyte-epithelial cell line culture (ML-AECL) was then incubated for 3 days, and harvested. As a control study, a one-way mixed lymphocyte culture (MLC) was also made up. Concentration of interleukin (IL) -10 in each supeynatant were assayd using an EASIA method. The concentration of IL-10 was not elevatedin MLC (9.3<plus-minus>11.8pg/ml, N=5) but significantly elev … More atedin ML-AECL (128<plus-minus>110pg/ml, N=5, p=0.043). Stimulation of B2B induceda population of allogeneic lymphocytes to proliferate and secrete IL-10. It has been reported that Th2, a subset of helper-T cells, secretes IL-10, which in turn inhibits both Th1 and cytotoxic T cells (CTLs) from proliferating and becoming active. We suggest that airway epithelial cells stimulate Th2, and, as a result, may play a role is suppressiing the allospecific reaction in acute rejection.Second, we investigated the role of costimulatory molecules on B2B.B2B were pretreated with either anti-HLA class I,anti-HLA class II,anti : ICAM-1, anti-LFA-3, or anti-B7 monoclonal antibody, Then the ML-AECL culture was then incubated, and harvested. Cell proliferation assay was performed using the colorimetric (MTT) assay. The MTT indeces (percentages relative to the control) were found to be significantly lower than the control when HLA class I,class II or LFA-3 on B2B was masked. In mixed culture consisting of B2B cells as stimulators and allogeneic lymphocytes, the lymphocytes recognized MHC-class I and II antigens expressed on the BEAS-2B.LFA-3 on BEAS-2B also contributed to the activation of lymphocyte alloreactivity. Less
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Nakajima J, Furuse A, et al: "Hemoptysis from emphysematous bulla following open heart surgery." Surgery Today. (in press). (1996)
Nakajima J、Furuse A 等人:“心脏直视手术后肺气肿大疱导致咯血。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中島 淳,他: "結節性硬化症に合併した過誤腫性肺脈管筋腫症-特異な臨床修飾が加えられた1例-" 日本胸部疾患学会雑誌. 33. 80-84 (1995)
Jun Nakajima 等人:“错构瘤性肺血管肌瘤病并发结节性硬化症 - 具有独特临床修改的病例”日本胸科疾病学会杂志 33. 80-84 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Oiwa, Jun Nakajima, Akira Furuse, et al: "[The distribution of FK506 in the blood and other organs on a non-human primate model of lung transplantation] (Japanese manuscript with English abstract)" Japanese Journal of Transplantation. 29. 144-148
Hiroshi Oiwa、Jun Nakajima、Akira Furuse 等人:“[FK506 在非人灵长类肺移植模型的血液和其他器官中的分布](日文手稿,英文摘要)”《日本移植杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Jun Nakajima: "Problems in xenografted lung of the primates.(in Update clinical immunology,Molecular Science in Organ Transplantation)" Pabst Science Publishers,Lengerich,Germany(出版中), 20 (1996)
Jun Nakajima:“灵长类异种移植肺的问题。(更新临床免疫学,器官移植中的分子科学)”Pabst Science Publishers,Lengerich,德国(印刷中),20(1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 27 条
    Development of cancer vaccine therapy targeting individual genetic mutations identified by next generation sequencing
    • 批准号:
      24659625
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      NAKAJIMA Jun
    • 依托单位:
    Determining factor of species richness in river based on species-area relation
    Clinical study on adoptive immunotherapy with autologous gammadelta T-lymphocyte for patients with pulmonary metastasis from colorectal cancer.
    • 批准号:
      21591809
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      NAKAJIMA Jun
    • 依托单位:
    Sustainable application of iron hybrid filter for arsenic removal
    • 批准号:
      20560511
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      NAKAJIMA Jun
    • 依托单位:
    国内基金
    PM2.5中典型POPs对人肺Beas-2B细胞炎性损伤机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      张亚楠
    • 依托单位:
    Drp1可逆性磷酸化在决定Cr(VI)暴露后BEAS-2B细胞发生早衰或恶性转化中的作用研究
    • 批准号:
      2020JJ3052
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      肖芳
    • 依托单位: